Table 3.

Facility-level variation of calcimimetic utilization for all patients on dialysis within Metropolitan Statistical Areas with the highest rates of calcimimetic use, 2018

Metropolitan Statistical AreaPatients Using Calcimimetics at All Facilities (%)“Maximum Facility” Calcimimetic Utilization (%)a“Minimum Facility” Calcimimetic Utilization (%)bIntra-MSA Percentage Point Difference between Maximum and Minimum Utilization
Killeen-Temple, Texas5073964
Reading, Pennsylvania48512923
Williamsport, Pennsylvania47503417
  • MSA, Metropolitan Statistical Area.

  • a Maximum facility refers to the facility within the MSA with the greatest proportion of all patients on dialysis using calcimimetic therapies.

  • b Minimum facility refers to the facility within the MSA with the lower proportion of all patients on dialysis using calcimimetic therapies.